Search

everythinglearnresearchcommunity

for

Search:↓

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Disrupted citric acid metabolism stops hair growth.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Trichothiodystrophy is a condition with brittle hair and various physical and mental issues due to low sulfur in proteins.

A baby with maple syrup urine disease improved from skin problems by adjusting his diet to correct amino acid levels.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

Many patients with Giant Cell Arteritis did not follow their steroid treatment plans properly.

AQB reduces harmful skin changes in systemic sclerosis.

Hair thinning and loss in a girl with a rare metabolic disorder was linked to her condition.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Croton membranaceus root extract can change how drugs are processed in the body.